| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer | EVP, Chief Medical Officer +2 more
5 companies
Smith Karen L. is a Director at SGMO with holdings across 5 companies. Recent SEC Form 4 filings include 4 buys and 1 sell.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sale+OE | 5,241 | $8.43 | $44,181.63 | -29.3% | -6.1% | +84.7% | |
| Aug 12, 2016 | JAZZ Jazz Pharmaceuticals Plc | Global Head Of R&D And CMO | Buy | 608 | $137.10 | $83,355.51 | +2.2% | - | - | |
| Jul 13, 2016 | JAZZ Jazz Pharmaceuticals Plc | Global Head Of R&D And CMO | Buy | 580 | $143.63 | $83,304.82 | +4.5% | - | - | |
| Jun 13, 2016 | JAZZ Jazz Pharmaceuticals Plc | Global Head Of R&D And CMO | Buy | 557 | $149.61 | $83,335.11 | +4.5% | - | - |